Linc AB (LINC) - Net Assets
Based on the latest financial reports, Linc AB (LINC) has net assets worth Skr4.43 Billion SEK (≈ $476.85 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr4.44 Billion ≈ $478.10 Million USD) and total liabilities (Skr11.62 Million ≈ $1.25 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Linc AB (LINC) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr4.43 Billion |
| % of Total Assets | 99.74% |
| Annual Growth Rate | 22.59% |
| 5-Year Change | 21.97% |
| 10-Year Change | N/A |
| Growth Volatility | 27.5 |
Linc AB - Net Assets Trend (2018–2025)
This chart illustrates how Linc AB's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of Linc AB for the complete picture of this company's asset base.
Annual Net Assets for Linc AB (2018–2025)
The table below shows the annual net assets of Linc AB from 2018 to 2025. For live valuation and market cap data, see market cap of Linc AB.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr4.43 Billion ≈ $476.85 Million |
-8.27% |
| 2024-12-31 | Skr4.83 Billion ≈ $519.86 Million |
+36.88% |
| 2023-12-31 | Skr3.53 Billion ≈ $379.78 Million |
+21.29% |
| 2022-12-31 | Skr2.91 Billion ≈ $313.12 Million |
-19.91% |
| 2021-12-31 | Skr3.63 Billion ≈ $390.96 Million |
+45.65% |
| 2020-12-31 | Skr2.49 Billion ≈ $268.42 Million |
+50.16% |
| 2019-12-31 | Skr1.66 Billion ≈ $178.75 Million |
+55.99% |
| 2018-12-31 | Skr1.06 Billion ≈ $114.60 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Linc AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 206.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Skr3.26 Billion | 73.53% |
| Common Stock | Skr5.79 Million | 0.13% |
| Other Components | Skr1.17 Billion | 26.34% |
| Total Equity | Skr4.43 Billion | 100.00% |
Linc AB Competitors by Market Cap
The table below lists competitors of Linc AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Daewon Cable Co. Ltd. Preference Shares
KO:006345
|
$458.78 Million |
|
Zinzino AB Series B
ST:ZZ-B
|
$458.82 Million |
|
Dalian Thermal Power Co Ltd
SHG:600719
|
$458.84 Million |
|
Liaoning He Eye Hospital Group Co. LTD.
SHE:301103
|
$459.02 Million |
|
Oron Group Investments & Holdings Ltd
TA:ORON
|
$458.54 Million |
|
Ion Beam Applications SA
BR:IBAB
|
$458.45 Million |
|
Yaxing Chem
SHG:600319
|
$458.41 Million |
|
Importadora y Exportadora de la Patagonia SA
BA:PATA
|
$458.39 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Linc AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,830,658,000 to 4,431,012,000, a change of -399,646,000 (-8.3%).
- Net loss of 399,647,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-399.65 Million | -9.02% |
| Other Changes | Skr1.00K | +0.0% |
| Total Change | Skr- | -8.27% |
Book Value vs Market Value Analysis
This analysis compares Linc AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.96x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 4.25x to 0.96x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | Skr17.33 | Skr73.60 | x |
| 2019-12-31 | Skr27.04 | Skr73.60 | x |
| 2020-12-31 | Skr40.60 | Skr73.60 | x |
| 2021-12-31 | Skr72.11 | Skr73.60 | x |
| 2022-12-31 | Skr50.24 | Skr73.60 | x |
| 2023-12-31 | Skr60.94 | Skr73.60 | x |
| 2024-12-31 | Skr83.42 | Skr73.60 | x |
| 2025-12-31 | Skr76.51 | Skr73.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Linc AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -9.02%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4118.37%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.00x
- Recent ROE (-9.02%) is below the historical average (13.59%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 29.67% | 5509.70% | 0.01x | 1.00x | Skr209.44 Million |
| 2019 | 35.89% | 12868.10% | 0.00x | 1.00x | Skr430.07 Million |
| 2020 | 33.40% | 63553.01% | 0.00x | 1.06x | Skr583.76 Million |
| 2021 | -0.83% | -725.69% | 0.00x | 1.04x | Skr-393.32 Million |
| 2022 | -24.86% | -30507.59% | 0.00x | 1.00x | Skr-1.01 Billion |
| 2023 | 17.55% | 16971.48% | 0.00x | 1.00x | Skr266.55 Million |
| 2024 | 26.94% | 10846691.67% | 0.00x | 1.00x | Skr818.54 Million |
| 2025 | -9.02% | -4118.37% | 0.00x | 1.00x | Skr-842.75 Million |
Industry Comparison
This section compares Linc AB's net assets metrics with peer companies in the Asset Management industry.
Industry Context
- Industry: Asset Management
- Average net assets among peers: $1,877,651,554
- Average return on equity (ROE) among peers: 7.71%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Linc AB (LINC) | Skr4.43 Billion | 29.67% | 0.00x | $458.68 Million |
| Athanase Innovation AB (ATIN) | $276.69 Million | 2.56% | 1.57x | $37.61 Million |
| Bure Equity AB (BURE) | $2.32 Billion | -2.53% | 0.13x | $2.13 Billion |
| Case Group AB (CASE) | $66.36 Million | 50.67% | 0.30x | $84.16 Million |
| Catella AB A (CAT-A) | $958.00 Million | -3.44% | 3.09x | $5.29 Million |
| Catella AB (publ) (CAT-B) | $980.00 Million | 2.14% | 2.99x | $197.61 Million |
| Creades AB (CRED-A) | $7.95 Billion | 45.87% | 0.05x | $711.38 Million |
| Effnetplattformen Holding AB (EFFH) | $32.81 Million | 5.13% | 0.11x | $6.51 Million |
| EQT AB (publ) (EQT) | $6.00 Billion | 2.16% | 0.53x | $37.38 Billion |
| First Venture Sweden AB Series B (FIRST-B) | $178.95 Million | -22.94% | 0.16x | $5.38 Million |
| Flat Capital AB Series B (FLAT-B) | $4.60 Million | -2.51% | 0.01x | $329.18 Million |
About Linc AB
Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and o… Read more